DEADLINE ALERT for RCKT, DDD, TEM, RDDT: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

(NasdaqGM:RCKT),(NYSE:DDD),(NASDAQ:TEM),(NYSE:RDDT), BENSALEM, Pa., Aug. 11, 2025 (GLOBE NEWSWIRE) — Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. Investors suffering losses on their investments are encouraged to […]

Deadline Alert: Flywire Corporation (FLYW) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

(NASDAQ:FLYW), LOS ANGELES, Aug. 11, 2025 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP reminds investors of the upcoming September 23, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Flywire Corporation (“Flywire” or the “Company”) (NASDAQ: FLYW) securities between February 28,

Deadline Alert: iRobot Corporation (IRBT) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

(NASDAQ:IRBT), LOS ANGELES, Aug. 11, 2025 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP reminds investors of the upcoming September 5, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired iRobot Corporation (“iRobot” or the “Company”) (NASDAQ: IRBT) securities between January 29,

DEADLINE ALERT for RCKT, DDD, TEM, RDDT: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

DEADLINE ALERT for RCKT, DDD, TEM, RDDT: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions GlobeNewswire August 11, 2025 BENSALEM, Pa., Aug. 11, 2025 (GLOBE NEWSWIRE) — Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of

National Advertising Review Board Recommends T-Mobile Discontinue Certain Comparative Savings Claims for its Mobile Telephone Service

National Advertising Review Board Recommends T-Mobile Discontinue Certain Comparative Savings Claims for its Mobile Telephone Service A panel of BBB National Programs' National Advertising Review Board (NARB), the appellate advertising body of BBB National Programs, has recommended that T-Mobile US, Inc. discontinue the express savings claims. GlobeNewswire August 11, 2025 New York, NY, Aug. 11,

Deadline Alert: Flywire Corporation (FLYW) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

Deadline Alert: Flywire Corporation (FLYW) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit GlobeNewswire August 11, 2025 LOS ANGELES, Aug. 11, 2025 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP reminds investors of the upcoming September 23, 2025 deadline to file a lead plaintiff motion in the

Deadline Alert: iRobot Corporation (IRBT) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

Deadline Alert: iRobot Corporation (IRBT) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit GlobeNewswire August 11, 2025 LOS ANGELES, Aug. 11, 2025 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP reminds investors of the upcoming September 5, 2025 deadline to file a lead plaintiff motion in the

Tevogen Bio Oncology Reports Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion; Forecasts for Non-Oncology Therapeutic Areas to Follow

(NasdaqGM:TVGN),(NASDAQ:TVGNW), Total eligible patients in the US exceed 2 million. Treatment of SARS-CoV-2 infection in solid and hematologic cancer patients under active treatment. Reflects business philosophy of commercial success through patient accessibility. WARREN, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) — Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech

Tevogen Bio Oncology Reports Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion; Forecasts for Non-Oncology Therapeutic Areas to Follow

Tevogen Bio Oncology Reports Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion; Forecasts for Non-Oncology Therapeutic Areas to Follow GlobeNewswire August 11, 2025 Total eligible patients in the US exceed 2 million. Treatment of SARS-CoV-2 infection in solid and hematologic cancer patients under active

Securities Class Action Lawsuit Filed Against iRobot Corporation (IRBT) – Levi & Korsinsky Represents Shareholders

NEW YORK, NY / ACCESS Newswire / August 11, 2025 / If you suffered a loss on your iRobot Corporation (NASDAQ:IRBT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/irobot-corporation-lawsuit-submission-form?prid=160872&wire=1&utm_campaign=13 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Scroll to Top